WHO urges rapid expansion of new HIV prevention tools amid funding crisis
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
Despite steep funding setbacks, the global HIV response has gained momentum in 2025 with the introduction of twice-yearly injectable LEN
In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic
Total income for the period stood at Rs. 7101.28 crore
Net profit for the half-year rose to Rs. 410 crore from Rs. 351 crore
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
The quarter included three IPOs worth US$ 428 million and one Qualified Institutional Placement (QIP) worth US$ 88 million
The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
AstraZeneca to invest $50bn in manufacturing and R&D to support domestic sourcing
Subscribe To Our Newsletter & Stay Updated